Price is the most common search pattern in the oral GLP-1 category, and also the most misleading. Headline prices like "$99/month oral semaglutide" exist, but they almost always refer to a specific starter-dose tier, for a specific time window, with specific program conditions attached. What you actually pay over a year of treatment — across dose escalation, follow-up visits, and titration failures — often looks different from the first-month promotional rate.
This guide is a plain-English breakdown of the cheapest legitimate oral GLP-1 pathways as of April 2026. "Legitimate" here means providers with LegitScript certification or equivalent compliance standing, real pharmacies, and actual clinical oversight — not the shadow-market compounders whose products FDA has flagged in recent warning letters.
The cheapest FDA-approved oral GLP-1 paths
The 2025–2026 launches of NovoCare Direct pricing and LillyDirect have reset the cost floor for FDA-approved oral GLP-1s. For the first time, brand-name pricing is genuinely competitive with compounded alternatives at the starter-dose tier.
Wegovy pill starter — $149/month
Launched January 2026 alongside FDA approval of the 25 mg oral Wegovy tablet. The 1.5 mg starter dose is priced at $149/month self-pay through NovoCare Direct. This is the cheapest FDA-approved weight-loss-indicated oral GLP-1 available to cash payers as of April 2026.
The caveat: $149 is the starter-dose price. When you escalate to the 9 mg maintenance dose (typically around month 3–4), the price rises to $299/month. So the true annualized cost for a patient who stays on Wegovy pill maintenance is closer to $3,200–$3,500 for the medication alone. That's still cheaper than injectable Wegovy's cash-pay tier and competitive with most compounded programs over the same 12-month window.
Foundayo starter — $149/month
Eli Lilly's small-molecule orforglipron. FDA approved April 1, 2026; launched through LillyDirect on April 6, 2026. Starter dose (0.8 mg) priced at $149/month self-pay. Maintenance-tier pricing is still being finalized as the drug rolls out through pharmacies.
Foundayo's distinctive advantage beyond price: no food or water restrictions. For patients who struggle with the Wegovy pill's 30-minute fasting window, Foundayo is a meaningful quality-of-life upgrade at the same starter-tier price.
Both programs require the patient to be paying cash (not using insurance). They're designed for uninsured or under-insured patients who would otherwise not be able to afford the medications. If you have insurance that covers the drug, you usually can't also use the manufacturer-direct cash pricing. If your insurance covers it partially, you might get a lower final price with insurance plus a manufacturer copay card than with NovoCare/LillyDirect — depends on the specifics.
The cheapest compounded oral GLP-1 paths
The compounded oral GLP-1 market is fragmented. Prices range from around $147/month at the budget end to $399/month for premium offerings. The cheapest providers in our audit:
Wellorithm — $147/month
A compounded-only telehealth platform with bare-bones pricing. $147/month for oral semaglutide drops or tablets, consult included. The low price is achieved primarily by cutting clinical touchpoints — follow-ups are sparse compared to bundled competitors. Wellorithm operates in most U.S. states and holds LegitScript certification.
Care Bare Rx — $199/month
Bundled program covering medication plus unlimited clinician visits plus shipping. More clinical support than Wellorithm, at a $52/month premium. Covered in detail in our Care Bare Rx review.
SHED drops — $229/month
LegitScript-certified with format variety across drops, lozenges, tablets, and gummies. More expensive than the bargain-basement compounders but the offering is more substantial. Covered in detail in our SHED review.
MangoRx Slim — $299/month
Publicly traded parent company (NASDAQ: MGRX), named pharmacy partner (Epiq Scripts with URAC/ACHC/LegitScript), flavored ODT format. Premium pricing reflects the transparency and operational stack. Covered in detail in our MangoRx review.
The cheapest paths with insurance coverage
If you have commercial insurance that covers any oral GLP-1, the math often changes substantially. Here's how it typically breaks down:
Rybelsus with diabetes indication
Rybelsus is FDA-approved for type 2 diabetes, and most commercial insurance plans cover it. With standard prior authorization plus a Novo Nordisk copay card for eligible commercially-insured patients, the final patient cost can come down to as low as $25–$100/month. This is the cheapest legitimate oral GLP-1 pathway available, if you qualify (meaning you have diabetes, commercial insurance, and no exclusions in your plan formulary).
Wegovy pill with obesity coverage
Coverage for the Wegovy pill for obesity is still limited as of April 2026 because the drug is new. Some commercial plans cover it with prior authorization (documented BMI ≥30, or ≥27 with comorbidity). Medicare does not cover weight-loss medications as a category. With insurance plus a Novo Nordisk savings card, the out-of-pocket cost for eligible patients can come down to roughly $25–$150/month.
Foundayo with commercial coverage
Coverage patterns for Foundayo are still developing since the drug launched in April 2026. Lilly's savings-card structure typically mirrors their other obesity medications (Zepbound), and initial indications suggest eligible commercially-insured patients may access out-of-pocket pricing in the $25–$100/month range. Expect this picture to evolve through 2026.
Compounded: insurance rarely helps
Almost no insurance plans cover compounded weight-loss medications. If you're paying cash for compounded products, you're paying the sticker price. This is a core reason the FDA-approved side of the market looks more competitive on price than it did two years ago — compounded used to be the only affordable path; now it's a tied race or worse for many patients with coverage.
Side-by-side price comparison
| Option | Monthly cost | Type | Annualized (approx.) |
|---|---|---|---|
| Rybelsus + commercial insurance + copay card | $25–$100 | FDA-approved | $300–$1,200 |
| Wegovy pill + commercial insurance + savings card | $25–$150 | FDA-approved | $300–$1,800 |
| Wellorithm compounded sema | $147 | Compounded | ~$1,770 |
| Wegovy pill starter (NovoCare Direct) | $149 | FDA-approved | $1,800–$3,500* |
| Foundayo starter (LillyDirect) | $149 | FDA-approved | ~$1,800+* |
| Care Bare Rx bundled | $199 | Compounded | ~$2,400 |
| SHED sublingual drops | $229 | Compounded | ~$2,750 |
| MangoRx Slim | $299 | Compounded | ~$3,600 |
| Wegovy pill maintenance (NovoCare Direct) | $299 | FDA-approved | ~$3,600 |
| Rybelsus cash-pay (no insurance) | $900–$1,400 | FDA-approved | $10,800–$16,800 |
*Annualized cost for starter-tier FDA-approved options includes the step-up to maintenance pricing around month 3–4.
Hidden costs to watch for
The advertised monthly price often isn't the total cost of the program. Things to check before you sign up:
Telehealth visit fees stacked separately
Visit-based platforms (like Sesame Care) charge medication and visit fees separately. The $149/month Wegovy pill price doesn't include the clinician visit — that's an additional $50–$80 for initial consults and less for follow-ups. Bundled programs (Care Bare Rx, MangoRx) fold this in, but at a higher monthly rate.
Dose escalation pricing tiers
Most providers price by dose. Starter doses are cheap; maintenance doses cost more. The Wegovy pill jumps from $149 to $299 at 9 mg. Some compounders double the price at higher doses. Always ask what the maintenance-tier monthly rate is, not just the starter rate.
Automatic refills and cancellation policies
Most oral GLP-1 telehealth platforms default to auto-renewing subscriptions. You keep getting charged until you proactively cancel. Some require 7–14 day cancellation notice before the next bill. Read the terms — accidental renewals are a common customer complaint across the category.
Shipping and handling
Most bundled programs include shipping. Some visit-based programs don't — shipping to you from the pharmacy is separate and can add $10–$25 per shipment.
Required lab work
Most platforms request or require baseline labs (liver, kidney, A1c, lipid panel). Some include this in the program cost; others send you to your own PCP or LabCorp. Expect $50–$150 out of pocket for labs if they're not bundled.
A patient seeing the "$149/month Wegovy pill!" headline and signing up through a visit-based telehealth could easily end up paying: $149 medication + $75 initial telehealth visit + $40 follow-up visit in month 2 + $30 shipping + $100 in baseline labs = ~$394 first-month out of pocket. Month 2 might drop to $149 + $30 shipping = $179. Month 4, when the dose escalates: $299 + $30 = $329. The "headline $149" averages out to closer to $220–$280/month for the first year, not $149.
How to actually compare providers
A five-question framework to evaluate any oral GLP-1 program:
- What's the full first-month cost? Include medication, consult, labs, and shipping. This is the number you'll actually pay.
- What's the price at maintenance dose? Not starter dose. You'll be on maintenance for most of the treatment period.
- What happens if I cancel? How much notice is required, and what's the refund policy?
- Is the pharmacy named? Compounded platforms that won't name their pharmacy partner are a yellow flag.
- What's the regulatory posture? LegitScript certified? Any FDA warning letters in the past 12 months? Checking takes 30 seconds.
Apply those five questions to each provider on your short list and the cheapest "real" option usually becomes obvious. It's often not the one with the cheapest advertised first-month price.
Care Bare Rx — cheapest bundled compounded program
$199/month covers medication, clinical visits, and shipping. HSA/FSA accepted. 50 states plus Puerto Rico. LegitScript-certified with no FDA warning letters.
Sesame Care — cheapest path to FDA-approved Wegovy pill
Novo Nordisk Recognized Care Provider. $149/month Wegovy pill starter through NovoCare Direct. FDA-approved medications only.